Search results
Results from the WOW.Com Content Network
Kiran Mazumdar-Shaw (born 23 March 1953) is an Indian billionaire entrepreneur. [3] She is the executive chairperson and founder of Biocon Limited and Biocon Biologics Limited, [4] a biotechnology company based in Bangalore, India [5] and the former chairperson of Indian Institute of Management, Bangalore. [6]
Mindtree Limited was an Indian multinational information technology services and consulting company, headquartered in Bangalore.Mindtree was acquired by Larsen & Toubro in 2019, before being merged with L&T Infotech (LTI) in 2022 to form LTIMindtree.
The Infosys Prize is an annual award granted to scientists, researchers, engineers and social scientists of Indian origin (not necessarily born in India) [1] ...
In 2006, Infosys bought out Citibank's share at a price of ₹592 per share, Citibank having invested at ₹0.20 per share. [4] It opened its first international office in Brno, Czech Republic in 2004 to support its European clients. In 2006, its employee strength reached 10,000 and its name was changed from Progeon Limited to Infosys BPO Limited.
The equity shares of Tata Power are listed on the Bombay Stock Exchange, [35] where it is a constituent of the BSE SENSEX index, [36] and the National Stock Exchange of India, [37] where it is a constituent of the NIFTY 50. [38] Its Global Depository Receipts (GDRs) are listed on the London Stock Exchange [39] and the Luxembourg Stock Exchange ...
Housing Development Finance Corporation was an Indian private sector mortgage lender based in Mumbai. [9] [10] It was the biggest housing finance company in India. [11]It also had a presence in banking, life and general insurance, asset management, venture capital and deposits through its associate and subsidiary companies.
The share prices [114] of RIL were impacted by some margin when this news broke out. In 2005, after a bitter public feud between the brothers over the control of the Reliance empire, mother Kokilaben intervened to broker a deal splitting the RIL group business into two parts. [ 115 ]
Divi's Laboratories has between 60 and 85% global market share in generic naproxen, dextromethorphan and gabapentin APIs. [14] The company currently has between 20 and 30% global market share in pregabalin and methylamine APIs. [14] The company's API production is backwards integrated. [15]